Auvi-Q has 11 known drug interactions based on U.S. FDA drug labeling data. 3 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Anti-Arrhythmics, Cardiac Glycosides, Diuretics. Patients taking Auvi-Q should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 11
- Major
- 3
- Moderate
- 8
Major (3)
- Auvi-Q + Anti-Arrhythmics— Increased risk of cardiac arrhythmias when used with epinephrine; careful observation required.
- Auvi-Q + Cardiac Glycosides— Increased risk of cardiac arrhythmias when used with epinephrine; careful observation required.
- Auvi-Q + Diuretics— Increased risk of cardiac arrhythmias when used with epinephrine; careful observation required.
Moderate (8)
- Auvi-Q + Chlorpheniramine— Antihistamine that may potentiate the effects of epinephrine.
- Auvi-Q + Diphenhydramine— Antihistamine that may potentiate the effects of epinephrine.
- Auvi-Q + Ergot Alkaloids— May reverse the pressor effects of epinephrine.
- Auvi-Q + Levothyroxine Sodium— May potentiate the effects of epinephrine.
- Auvi-Q + Monoamine Oxidase Inhibitors (Maois)— May potentiate the effects of epinephrine.
- Auvi-Q + Phentolamine— Alpha-adrenergic blocker that antagonizes the vasoconstricting and hypertensive effects of epinephrine.
- Auvi-Q + Propranolol— Beta-adrenergic blocker that antagonizes the cardiostimulating and bronchodilating effects of epinephrine.
- Auvi-Q + Tripelennamine— Antihistamine that may potentiate the effects of epinephrine.